SCHEMBL693264

SCHEMBL693264

COC1=NCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL343554 0.92
SCHEMBL5098521 0.90 NOS3 (0.42)
SCHEMBL8446266 0.90 NOS3 (0.42)
SCHEMBL8268847 0.90 NOS3 (0.42)
SCHEMBL5865174 0.90 NOS3 (0.42)
SCHEMBL5865181 0.90 NOS3 (0.42)
SCHEMBL5098524 0.90 NOS3 (0.42)
SCHEMBL2382858 0.90 NOS3 (0.42)
SCHEMBL2382862 0.90 NOS3 (0.42)
SCHEMBL5865176 0.90 NOS3 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 348 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11465988-B2 Process for the preparation of Tipiracil hydrochloride and intermediates thereof NATCO PHARMA LIMITED (IN) 2022-10-11 US claimed
WO-2022104599-A1 N-HETEROCYCLIC CARBENE CATALYST AND PREPARATION METHOD THEREFOR 深圳湾实验室坪山生物医药研发转化中心 2022-05-27 WO claimed
US-20220056016-A1 IMPROVED PROCESS FOR THE PREPARATION OF TIPIRACIL HYDROCHLORIDE AND INTERMEDIATES THEREOF NATCO PHARMA LIMITED (IN) 2022-02-24 US claimed
EP-3265500-A1 WATER BASED PRIMER COMPOSITION H. B. Fuller Company (US) 2018-01-10 EP claimed
WO-2016144753-A1 WATER BASED PRIMER COMPOSITION H.B. FULLER COMPANY (US) 2016-09-15 WO claimed
CN-101066967-B Synthesis process of dibenzo dioxy octanone compound UNIV FUDAN 2010-11-10 CN claimed
CN-101066967-A Synthesis process of dibenzo dioxy octanone compound UNIV FUDAN (CN) 2007-11-07 CN claimed
US-20260124204-A1 METALLOENZYME INHIBITOR COMPOUNDS EIKONIZO THERAPEUTICS, INC. (US) 2026-05-07 US disclosed
EP-4731626-A1 PI3K INHIBITORS AND USE THEREOF Regor Pharmaceuticals, Inc. (US) 2026-04-29 EP disclosed
EP-4720040-A1 SULFONAMIDE COMPOUNDS BENEFICIAL IN NEUROPROTECTIVE TREATMENT Lario Therapeutics Limited (GB) 2026-04-08 EP disclosed
EP-4720061-A1 TREM2 AGONISTS F. Hoffmann-La Roche AG (CH) 2026-04-08 EP disclosed
US-20260060985-A1 Compounds for the Prevention and Treatment of Medical Disorders and Uses Thereof GALECTIN SCIENCES, LLC (US) 2026-03-05 US disclosed
US-20250333424-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2025-10-30 US disclosed
US-4130652-A 2-(Iminoethylidene)-pyrrolidines and tautomeric 2-(aminoethenyl)-1-pyrrolines CIBA-GEIGY CORPORATION (US) 1978-12-19 US disclosed
US-4126613-A HYPOGLYCEMIC, HYPOTENSIVE, ANTIINFLAMMATORY, ANTICOAGULANT, DIURETIC RICHARDSON-MERRELL INC. (US) 1978-11-21 US disclosed
US-4126621-A HYPOGLYCEMIC, HYPOTENSIVE, ANTIINFLAMMATORY, ANTICOAGULANT, DIURETIC RICHARDSON-MERRELL INC. (US) 1978-11-21 US disclosed
US-4126612-A HYPOGLYCEMIC, HYPOTENSIVE, ANTIINFLAMMATORY, ANTICOAGULANT, DIURETIC Retter, Eugene O. (US) 1978-11-21 US disclosed
US-4126611-A HYPOGLYCEMIC, HYPOTENSIVE, ANTIINFLAMMATORY, ANTICOAGULANT, DIURETIC RICHARDSON-MERRELL INC. (US) 1978-11-21 US disclosed
US-4061746-A Lactamimide inhibitors of gastrointestinal hypersecretion RICHARDSON-MERRELL INC. (US) 1977-12-06 US disclosed
US-4055561-A ANTICOAGULANT RICHARDSON-MERRELL INC. (US) 1977-10-25 US disclosed